Mural Oncology plc (MURA) Earning

$3.44

north_east
$0.02 (0.58%)
Day's range
$3.36
Day's range
$3.5

Mural Oncology plc Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2025 2 -$1.91 -$1.73 -$1.82
Q2 2025 1 -$1.18 -$1.18 -$1.18
Q3 2025 1 -$1.08 -$1.08 -$1.08
Q4 2025 1 -$1.12 -$1.12 -$1.12
Q1 2026 1 -$1.07 -$1.07 -$1.07
Q2 2026 1 -$1.07 -$1.07 -$1.07
Q3 2026 1 -$0.72 -$0.72 -$0.72
Q4 2026 1 -$0.66 -$0.66 -$0.66

Mural Oncology plc Earnings Date And Information

Mural Oncology plc last posted its earnings results on Tuesday, March 11th, 2025. The company reported $-2.01 earnings per share for the quarter, missing analysts' consensus estimates of $-1.98 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Mural Oncology plc has generated $-8 earnings per share over the last year ($-7.58 diluted earnings per share) and currently has a price-to-earnings ratio of -0.49. Mural Oncology plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 25th, 2025 based on prior year's report dates.

Mural Oncology plc Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
03/11/2025 Q4 2024 -$1.98 -$2.01 -0.03 $0 $0
11/13/2024 Q3 2024 -$1.96 -$1.87 0.09 $0 $0
08/13/2024 Q2 2024 -$1.90 -$1.86 0.04 $0 $0
05/14/2024 Q1 2024 -$2.66 -$1.84 0.82 N/A $0
03/26/2024 Q4 2023 N/A -$3.57 N/A N/A $2.62 M
12/14/2023 Q3 2023 N/A -$3.07 N/A N/A $0
06/29/2023 Q2 2023 N/A -$3.13 N/A N/A $0
03/30/2023 Q1 2023 N/A -$2.78 N/A N/A $0
12/30/2022 Q4 2022 N/A -$3.52 N/A N/A $0
09/29/2022 Q3 2022 N/A -$3.03 N/A N/A $0

Mural Oncology plc Earnings: FAQ's

Mural Oncology plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 25th, 2025 based offlast year's report dates.

The conference call for Mural Oncology plc's latest earnings report can be listened to online.

The conference call transcript for Mural Oncology plc's latest earnings report can be read online.

Mural Oncology plc (:MURA) has a recorded net income of $-128,514,000.Mural Oncology plc has generated $-7.58 earnings per share over the last four quarters.

Mural Oncology plc (:MURA) has a price-to-earnings ratio of -0.49 and price/earnings-to-growth ratio is -0.03.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED